Catalent to acquire gene-therapy service firm Paragon

The $1.2 billion deal is the latest designed to support the flood of gene therapies in development

Source: Chemical and Engineering News - April 20, 2019 Category: Chemistry Authors: Lisa M. Jarvis Source Type: research